grade
anhydrous
vapor pressure
<0.0001 hPa ( 25 °C)
product line
ReagentPlus®, Redi-Dri™
assay
≥99.0%
form
powder
autoignition temp.
914 °F
pH
9
mp
271 °C (lit.)
SMILES string
[Na+].[O-]N=O
InChI
1S/HNO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1
InChI key
LPXPTNMVRIOKMN-UHFFFAOYSA-M
Application
- Disodium nitrite, an additive compound of sodium nitrite and sodium.：本文研究亚硝酸二钠的形成和特性，它是一种由亚硝酸钠和钠反应形成的化合物。研究有助了解亚硝酸钠在各种工业反应中的化学性质和应用潜力(Journal of the Chemical Society, Transactions, 1917)。
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under 亚硝酸钠
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral - Aquatic Acute 1 - Eye Irrit. 2 - Ox. Sol. 3
存储类别
5.1B - Oxidizing hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
危险化学品
此项目有
商品
Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.
MOST offers controlled solar energy harvesting and storage, addressing global energy demands with improved storage techniques.
Lucas C Pinheiro et al.
Free radical biology & medicine, 53(4), 701-709 (2012-06-23)
The new pathway nitrate-nitrite-nitric oxide (NO) has emerged as a physiological alternative to the classical enzymatic pathway for NO formation from l-arginine. Nitrate is converted to nitrite by commensal bacteria in the oral cavity and the nitrite formed is then
Edward H Oldfield et al.
Journal of neurosurgery, 119(3), 634-641 (2013-05-28)
Intravenous sodium nitrite has been shown to prevent and reverse cerebral vasospasm in a primate model of subarachnoid hemorrhage (SAH). The present Phase IIA dose-escalation study of sodium nitrite was conducted to determine the compound's safety in humans with aneurysmal
Paul J Shami et al.
Journal of medicinal chemistry, 49(14), 4356-4366 (2006-07-11)
The literature provides evidence that metabolic nitric oxide (NO) release mediates the cytotoxic activities (against human leukemia and prostate cancer xenografts in mice) of JS-K, a compound of structure R(2)N-N(O)=NO-Ar for which R(2)N is 4-(ethoxycarbonyl)piperazin-1-yl and Ar is 2,4-dinitrophenyl. Here
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 901903-500G | 04061835336678 |
| 901903-2.5KG | 04061835336654 |